Morris Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Morris Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,955	Closed	-$356K	–	66
2019 Q4	$356K	Buy	+2,955	New	+$330K	0.3%	53
2018 Q1	–	Sell	-3,070	Closed	-$328K	–	76
2017 Q4	$328K	Buy	+3,070	New	+$328K	0.21%	60

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morris Capital Advisors's IBB Position: Q1 2020 in Review

Morris Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 2,955 shares — an estimated $356K sold.

Morris Capital Advisors first reported a position in IBB in Q4 2017 and held it in 2 quarters. The position peaked at $356K in Q4 2019. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Morris Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Morris Capital Advisors sold 2,955 iShares Biotechnology ETF shares in Q1 2020, an estimated $356K.
Morris Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 2 quarters.
Morris Capital Advisors's iShares Biotechnology ETF position peaked at $356K in Q4 2019.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Morris Capital Advisors's 13F filing for Q1 2020, filed 7 May 2020.